Sensus Healthcare, Inc.
SRTS Nasdaq· Surgical & Medical Instruments & Apparatus
Last close · Oct 26, 2026
$2.82
KIRA · Stoqly’s AI analyst, in plain words
- Sensus Healthcare, Inc. had $27.5M of revenue in fiscal 2025, down 34.3% on the year before. Over five years, revenue changed +23.5% a year on average.
- Its operating margin was −37.5%, down 56.9 pts: of every 100 in sales, about −38 is left after running the business.
- Sensus Healthcare, Inc. lost $7.7M in fiscal 2025.
- Free cash flow was $0.3M in fiscal 2025, 1.2% of revenue.
- Sensus Healthcare, Inc. returned $0.3M to shareholders in fiscal 2025, 90% of free cash flow. The diluted share count fell 0.2%.
Market cap
$46.4M
P/E
—
Revenue
$27.5M
Net income
−$7.7M
Free cash flow
$0.3M
Operating margin
−37.5%
Sensus Healthcare, Inc. in 30 seconds · fiscal 2025
Are sales growing?
−34.3%
No. Sales fell 34.3% last year.
Does it make a profit?
−28.1%
No. It lost money last year.
Does profit turn into cash?
1.2%
Partly. 1.2% of sales ends up as free cash.
How healthy are the accounts?
4 / 8
Mixed. It passes 4 of 8 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Sensus Healthcare, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 4, 2026
- Legal name
- Sensus Healthcare, Inc.
- CIK
- 0001494891
Sensus Healthcare, Inc. · SRTS
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $27.0M | $44.5M | $24.4M | $41.8M | $27.5M |
| Revenue growth | 182.4% | 64.7% | −45.2% | 71.3% | −34.3% |
| Net interest income | — | — | — | $0.9M | $0.7M |
| Gross margin | 62.8% | 66.5% | 57.6% | 58.4% | 43.2% |
| Operating margin | 15.2% | 33.3% | −1.6% | 19.4% | −37.5% |
| Net income | $4.1M | $24.2M | $0.5M | $6.6M | −$7.7M |
| Net margin | 15.2% | 54.4% | 2.0% | 15.9% | −28.1% |
| Diluted EPS | $0.25 | $1.46 | $0.03 | $0.41 | −$0.47 |
| Cash | |||||
| Cash from operations | −$0.3M | −$1.4M | −$2.1M | −$0.8M | $0.5M |
| Capital expenditure | $0.1M | $0.2M | $0.2M | $0.3M | $0.2M |
| Free cash flow | −$0.4M | −$1.6M | −$2.4M | −$1.1M | $0.3M |
| FCF margin | −1.5% | −3.5% | −9.7% | −2.6% | 1.2% |
| Share buybacks | — | $3.0M | $0.0M | — | $0.3M |
| Share count change | 0.4% | 0.7% | −2.1% | 0.6% | −0.2% |
| Debt and strength | |||||
| Cash and short-term investments | $14.5M | $25.5M | $23.1M | $22.1M | $22.1M |
| Shareholders' equity | $26.0M | $48.1M | $48.8M | $55.8M | $48.1M |
| Current ratio | 5.2x | 6.9x | 11.8x | 9.6x | 9.7x |
| Interest coverage | 2,060.0x | — | — | — | — |
| Returns and quality | |||||
| Return on equity | 17.3% | 65.5% | 1.0% | 12.7% | −14.9% |
| Return on tangible equity | 15.9% | 50.5% | 1.0% | 11.9% | −16.0% |
| Piotroski F-score | 5 | 4 | 3 | 4 | 4 |
| Altman Z'' | 8.6 | 13.2 | 16.4 | 16.2 | 14.4 |
Insiders bought, 12 months
$0.7M
3 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Sensus Healthcare, Inc. · SRTS
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $2.82 a share, the company is worth $46.4M.
Source: SEC EDGAR XBRL filings (CIK 0001494891). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.